secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2024-05-01T23:59:59+00:00
Accession:  0001213900-24-038497
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics stockholders approve share issuance and equity plan increase at special meeting
--------------------------------------------------------------------------------

- Ratified Wolf & Company as independent auditor for 2024, with 8.32M votes for.
- Approved issuance of common stock upon conversion of Series A and B preferred and warrants.
- Approved issuance under Committed Equity Financings arrangement.
- Amended 2024 Equity Incentive Plan, increasing authorized shares by 2,000,000.
- All proposals passed with over 98% of votes cast in favor; quorum of 56.9% of shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024038497/0001213900-24-038497-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024038497/ea0205118-8k_cerothera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-038497

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer